CVS Health
CVS
#222
Rank
$77.04 B
Marketcap
$61.37
Share price
0.61%
Change (1 day)
-11.58%
Change (1 year)

P/E ratio for CVS Health (CVS)

P/E ratio as of June 2024 (TTM): 9.15

According to CVS Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.1539. At the end of 2022 the company had a P/E ratio of 28.5.

P/E ratio history for CVS Health from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202228.565.75%
202117.237.95%
202012.5-14.61%
201914.6-112.25%
2018-119-1164.75%
201711.2-29.96%
201616.0-23.7%
201520.9-13.27%
201424.127.49%
201318.920.22%
201215.7-0.36%
201115.814.56%
201013.810.52%
200912.5-3.13%
200812.9-36.13%
200720.27.71%
200618.76%
200517.7-10.99%
200419.917.08%
200317.021.56%
200213.9-51.93%
200129.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.15-145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-15.2-266.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0219-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.